centchroman has been researched along with Bone Loss, Osteoclastic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Narayana Murthy, PS; Sengupta, S; Sharma, S; Singh, MM | 1 |
Arshad, M; Ghosh, R; Sawlani, V; Sengupta, S; Sharma, S; Singh, MM | 1 |
Fournier, B; Hall, TJ; Nyugen, H; Schaueblin, M | 1 |
Blair, HC; Jordan, SE; McDonald, JM; McKenna, MA; Radding, W; Williams, JP | 1 |
4 other study(ies) available for centchroman and Bone Loss, Osteoclastic
Article | Year |
---|---|
Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Topics: Animals; Apoptosis; Benzopyrans; Bone Density; Bone Marrow Cells; Bone Resorption; Calcium; Cell Differentiation; Cells, Cultured; Female; Lumbar Vertebrae; Mice; Mice, Inbred BALB C; Organ Size; Osteoclasts; Ovariectomy; Phosphorus; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Stem Cells; Transforming Growth Factor beta; Transforming Growth Factor beta3; Uterus | 2006 |
In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
Topics: Animals; Autopsy; Benzopyrans; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Calcium; Centchroman; Chick Embryo; Densitometry; Disease Models, Animal; Epithelial Cells; Ethinyl Estradiol; Female; Femur; Osteocalcin; Osteoporosis; Ovary; Parathyroid Hormone; Piperidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen; Tibia | 2004 |
The bone-specific estrogen centchroman inhibits osteoclastic bone resorption in vitro.
Topics: Animals; Animals, Newborn; Bone Resorption; Calcitonin; Cells, Cultured; Centchroman; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Humans; Kinetics; Molecular Structure; Osteoclasts; Piperidines; Raloxifene Hydrochloride; Rats; Structure-Activity Relationship | 1995 |
Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding.
Topics: Animals; Anticarcinogenic Agents; Benzopyrans; Bone Resorption; Calmodulin; Centchroman; Cyclic Nucleotide Phosphodiesterases, Type 1; Dose-Response Relationship, Drug; Female; Osteoclasts; Phosphoric Diester Hydrolases; Piperidines; Proton-Translocating ATPases; Tamoxifen; Trifluoperazine | 1997 |